Renal Carcinoma (Clear and Non-clear Cell)
1 clinical trials · Condition
◉ Watch Renal Carcinoma (Clear and Non-clear Cell)
| Record | Firm | Date |
|---|---|---|
| Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors (NCT07517198) | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 2026-04-13 |
Track Renal Carcinoma (Clear and Non-clear Cell) automatically
Every clearance here is in the API, with alerts when new ones post.